Literature DB >> 19216682

Genetic diversity of the low-level vancomycin resistance gene vanC-2/vanC-3 and identification of a novel vanC subtype (vanC-4) in Enterococcus casseliflavus.

Shojiro Watanabe1, Nobumichi Kobayashi, Dianelys Quiñones, Satoshi Hayakawa, Shigeo Nagashima, Nobuyuki Uehara, Naoki Watanabe.   

Abstract

An intrinsic low-level vancomycin resistance (VanC phenotype) in Enterococcus casseliflavus is conferred by either of two subtypes of vanC genes, that is, vanC-2 or vanC-3, which are genetically closely related. To know genetic diversity of vanC-2/C-3 genes among E. casseliflavus, nucleotide sequences of vanC-2/C-3 and other genetic components in vanC gene cluster (vanXYc, vanTc, vanRc, and vanSc) were analyzed for nine clinical isolates and four standard strains that showed low-level vancomycin resistance. While the vanC-2/C-3 gene sequences showed 93-100% identities among the strains examined, two genetic groups were discriminated by phylogenetic analysis: one closely related to the previously reported vanC-2 or vanC-3 genes (vanC-2/C-3 genotype) with 98-100% identity, and the other distinct from the vanC-2/C-3 genotype (93-95% identity). The latter group found in three clinical isolates was considered as a new subtype of vanC and tentatively designated as vanC-4. Between strains with the vanC-2/C-3 genotype and those with vanC-4, vanXYc genes were also genetically discriminated with 92-93% identity. Similar sequence diversity was observed for vanTc, vanRc, and vanSc (88-93% identity). Clonal relatedness among the E. casseliflavus strains was investigated by phylogenetic analysis of atpA gene. While among E. casseliflavus strains with vanC-2/C-3 genotype, extremely high sequence identities of atpA were found (98.7% or higher), these strains showed slightly lower identity to those with vanC-4 (94-96%). These two groups of E. casseliflavus strains were also discriminated by genotyping with arbitrarily primed PCR. These findings indicated that among E. casseliflavus there are at least two genetic lineages with the distinct vanC genes, that is, a single subtype including previously known vanC-2/C-3, and a novel subtype vanC-4.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19216682     DOI: 10.1089/mdr.2009.0856

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  5 in total

1.  Clinical epidemiology of vancomycin-resistant Enterococcus gallinarum and Enterococcus casseliflavus bloodstream infections.

Authors:  Nicholas S Britt; Emily M Potter
Journal:  J Glob Antimicrob Resist       Date:  2015-12-21       Impact factor: 4.035

2.  Comparison of the Potency of the Lipid II Targeting Antimicrobials Nisin, Lacticin 3147 and Vancomycin Against Gram-Positive Bacteria.

Authors:  Catalin Iancu; Aoife Grainger; Des Field; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Probiotics Antimicrob Proteins       Date:  2012-06       Impact factor: 4.609

3.  Enterococcus innesii sp. nov., isolated from the wax moth Galleria mellonella.

Authors:  Harriet C C Gooch; Raymond Kiu; Steven Rudder; David J Baker; Lindsay J Hall; Anthony Maxwell
Journal:  Int J Syst Evol Microbiol       Date:  2021-12       Impact factor: 2.747

Review 4.  Regulation of Resistance in Vancomycin-Resistant Enterococci: The VanRS Two-Component System.

Authors:  Alexandra A Guffey; Patrick J Loll
Journal:  Microorganisms       Date:  2021-09-25

5.  Factorial design and post-antibiotic sub-MIC effects of linezolid combined with fosfomycin against vancomycin-resistant enterococci.

Authors:  Yisong Yan; Guang Yang; Yaowen Li; Jun Mao; Shuaishuai Wang; Na Zhang; Huiping Liu; Xiaohui Huang
Journal:  Ann Transl Med       Date:  2022-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.